Quest Diagnostics Incorporated
DGX · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $17 | $15 | $18 | $22 |
| - Cash | $1 | $1 | $0 | $1 |
| + Debt | $7 | $5 | $5 | $5 |
| Enterprise Value | $23 | $20 | $23 | $26 |
| Revenue | $10 | $9 | $10 | $11 |
| % Growth | 6.7% | -6.4% | -8.4% | – |
| Gross Profit | $3 | $3 | $3 | $4 |
| % Margin | 32.9% | 33.2% | 34.7% | 39% |
| EBITDA | $2 | $2 | $2 | $3 |
| % Margin | 19.2% | 18.7% | 18.4% | 29.3% |
| Net Income | $1 | $1 | $1 | $2 |
| % Margin | 8.8% | 9.2% | 9.6% | 18.5% |
| EPS Diluted | 7.69 | 7.52 | 7.98 | 15.53 |
| % Growth | 2.3% | -5.8% | -48.6% | – |
| Operating Cash Flow | $1 | $1 | $2 | $2 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | $1 | $1 | $2 |